UNSPSC 51433807: Cilazapril monohydrate

This classification denotes an ace inhibitor with the molecular structure C22H31N3O5.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 19KW7PI29F chemically known as (1s,9s)-9-(((s)-1-carboxy-3-phenylpropyl)amino)octahydro-10-oxo-6h-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid 9-ethyl ester monohydrate, but more commonly known as cilazapril, which bears US NIH Compound Identifier 56329. European Medicines Agency schedules Cilazapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06265MIG.

UNSPSC 51433807 Cilazapril monohydrate is a Commodity code in the pharmaceutical supply chain, but the single recent state and local opportunity posted under this code—the City of Tampa Fire Rescue medication procurement—does not actually solicit cilazapril monohydrate; instead, the City of Tampa's sealed-bid solicitation (IFB No. 26P00188, due April 8, 2026) requests four emergency-response medications: labetalol HCI, epinephrine, adenosine, and diltiazem. This code shows a mismatch between its nominal scope and current state and local buying activity. The broader context suggests that state and local governments do procure emergency pharmaceuticals through formal competitive bidding, with specific unit quantities, expiration-date requirements (nine months minimum shelf life in the Tampa case), delivery timelines (ten calendar days), and warranty provisions (365-day defect coverage). Issuing bodies include municipal fire and emergency services departments purchasing through their city procurement offices.

The Tampa opportunity represents activity in Florida and carries an estimated contract value of $40,000 with a one-year initial term and renewal options. The City of Tampa's use of a sheltered small local business enterprise (SLBE) set-aside with a 5 percent bid discount (capped at $10,000) reflects the competitive landscape for emergency pharmaceutical supply. No other recent opportunities under this specific code appear in the source, limiting visibility into geographic concentration or issuing-body diversity across state and local jurisdictions. Business development professionals should verify whether cilazapril monohydrate procurement occurs under different UNSPSC codes or whether this code assignment reflects a data classification issue rather than an active procurement category in state and local markets.